Rejected from Nature Structural and Molecular Biology? Where to Submit Next

In Manusights pre-submission and post-rejection review work on NSMB-targeted manuscripts, the recurring problem is not simply "not enough structure" or "not enough biology." The problem is misalignment between the structural evidence and the molecular or cellular claim. NSMB can value structural detail, but the structure normally has to explain a biological mechanism, not sit beside it as a technical achievement. The next journal choice should start with that diagnosis.

Evidence basis: Of the 40+ manuscripts we reviewed or pre-screened in this structural and molecular biology lane, the specific rejection pattern we see most often is an editorial triage pattern where the structure is publishable, but the claimed biological mechanism is not yet visible in the abstract, first figure, validation results, and limitations. Manusights review data also shows a second recurring pattern: authors treat an NSMB transfer suggestion as a destination decision instead of testing whether the receiving journal values the same version of the manuscript. SciRev community reports are only a supporting author-experience signal here, not the basis for an author-specific prediction.

Nature Structural and Molecular Biology pattern 1: the structure is technically strong but function is thin. Cryo-EM, crystallography, NMR, cross-linking, modeling, or biochemical data may be impressive, but the manuscript does not show what the structure changes in the biological story. If the figures stop at architecture and do not prove functional consequence, a structural-biology specialist route may fit better than another broad molecular journal.

Nature Structural and Molecular Biology pattern 2: the molecular biology is strong but structural insight is not central. Some papers contain compelling signaling, gene regulation, chromatin, RNA, protein-complex, or cell-biology data, but the structure is supportive rather than decisive. That paper may belong at Molecular Cell, EMBO Journal, Nucleic Acids Research, or a field-specific venue depending on the actual center of gravity.

Nature Structural and Molecular Biology pattern 3: validation does not support the mechanism. Model quality, map validation, resolution distribution, biochemical confirmation, mutagenesis, binding evidence, rescue data, statistics, deposition readiness, and orthogonal support all matter. If the rejection questioned support, the next submission should not only change the journal name.

Nature Structural and Molecular Biology pattern 4: broad significance is asserted rather than demonstrated. A cover letter may say the result changes the field, but the abstract and figure sequence may show a narrower system-specific result. That mismatch follows the paper to the next journal unless the claim is narrowed or the data are strengthened.

Nature Structural and Molecular Biology pattern 5: the transfer option is treated as fit. Springer Nature may offer a transfer route after rejection, and that can save administrative time. It does not mean the receiving journal will accept an unrevised manuscript or that its readers value the same version of the claim.

Nature Structural and Molecular Biology pattern 6: methods and supplementary files are not auditable enough. NSMB and neighboring journals expect readers to understand how the structure, model, validation, assay, and interpretation connect. If the supporting information carries too much of the argument, the next submission may repeat the same failure.

Check which NSMB rejection pattern your paper fits →

Start by separating fit from evidence. A fit rejection means the paper may be scientifically sound but not NSMB-shaped. An evidence rejection means the next journal will likely find the same problem unless you repair the manuscript. A significance rejection means the current claim may be too broad for the data, even if the structure and assays are technically credible.

For structural-biology papers, the strongest retargeting question is: what does the structure explain that the field could not explain before? If the answer is a molecular mechanism with functional consequence, Nature Communications, Molecular Cell, EMBO Journal, or a specialist route may remain plausible. If the answer is a detailed architecture of a complex with narrower biological reach, Structure or Journal of Molecular Biology may be cleaner. If the answer is mainly a nucleic-acid, chromatin, RNA, or genome mechanism, Nucleic Acids Research may fit better than a generic structural route.

Do not submit unchanged because the NSMB median first-decision time was short. A fast rejection may feel like the manuscript was not fully assessed, but it still signals that the editor did not see enough scope, novelty, or fit to send it forward. The retargeted version should make the center of gravity easier to see in the title, abstract, first figure, final model, and cover letter.

Use transfer only when the destination journal matches the repaired paper. If the offered journal values a narrower structural story, revise the claim accordingly. If the offered journal is broader, make sure the biological significance is visible without relying on NSMB context. Transfer speed is useful only when it avoids repeating a mismatch.

First, classify every editor or reviewer comment as scope, structure-function mechanism, validation, novelty, reporting, statistics, data availability, significance, or writing. Do not mix those categories. A manuscript with a scope problem needs a route decision. A manuscript with a validation problem needs a manuscript repair.

Second, reread the abstract, first figure, structural model, functional assay, mutagenesis or perturbation experiment, final mechanism figure, and cover letter together. If the structure-function claim is visible only after a long explanation, the next editor may miss it too. The first page and first figure should show why the structure matters biologically.

Third, write a one-paragraph retargeting memo before choosing a journal:

Fourth, revise the paper for the next journal's readers. A Structure submission should foreground structural mechanism and validation. A Molecular Cell or EMBO Journal submission should foreground biological mechanism and functional consequence. A Nucleic Acids Research submission should foreground the nucleic-acid question or data resource. A Scientific Reports submission should narrow the claim and make technical soundness clear.

Run an NSMB rejection and retargeting check →

This page is a post-rejection routing guide, not an official NSMB policy page. Nature Portfolio pages control the journal instructions, peer-review policy, metrics, and publishing options. Springer Nature controls transfer infrastructure. Manusights adds the author-side decision layer: whether the rejected manuscript should be repaired for a structure-function claim, routed to a broader biology journal, shifted to a structural-biology specialist venue, reframed for molecular biology, or narrowed for a technically sound journal.